Frontiers in Endocrinology | Cardiovascular Endocrinology

Review

Published on 10 Jul 2025

Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk

in Cardiovascular Endocrinology

Cong Wang
Haifeng Fu
Hao Xu
Handong Yang
Xinwen Min
Wenwen Wu
Zhixin Liu
Dongfeng Li
Yun Dong
Jun Chen

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1576602

278 views

Original Research

Published on 10 Jul 2025

Cardiovascular-kidney-metabolic comorbidities in colorectal cancer survivors: a nationwide cohort study on the role of metabolic syndrome

in Cardiovascular Endocrinology

Xin Liu
Wenbo Zhao
Chang Zheng

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1629675

196 views

Original Research

Published on 09 Jul 2025

Association between cardiometabolic Index and obstructive sleep apnea and the mediating role of smoking: a cross-sectional study

in Cardiovascular Endocrinology

Yifan Zhou
Jinghao Yu
Haitao Tan
Jun Xiao

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1609585

239 views

Original Research

Accepted on 08 Jul 2025

Associations of Triglyceride-Glucose Index and Metabolic Score for Insulin Resistance with Various Hypertension Phenotypes in Children and Adolescents: Results from the 2017 China Nutrition and Health Surveillance

in Cardiovascular Endocrinology

Haiyuan Zhu
Lianlong Yu
Qiqi Wu
Runquan Zhang
Zebang Zhang
Yumei Feng
Tao Liu
Dan Liu
Jiewen Peng
Xiongfei Chen

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1595097

Original Research

Accepted on 08 Jul 2025

Factors Associated with Hypertension among Type 2 Diabetic Patients: Evidence from Resource Limited Setting of Southern Ethiopia

in Cardiovascular Endocrinology

Begidu Yakob
Eskinder Israel
Mesfin Menza
Awoke Abiraham
Tagese Yakob

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1534852

Review

Accepted on 07 Jul 2025

Therapeutic potential of traditional Chinese medicine in diabetic cardiomyopathy: a review

in Cardiovascular Endocrinology

Wencan Li
Xiang Liu
Zheng Liu
Qichang Xing
Renzhu Liu
Qinxuan Wu
Jiani Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1532565

102 views

Original Research

Accepted on 07 Jul 2025

Serum Tyrosine increases All-Cause Mortality in an Older Population

in Cardiovascular Endocrinology

Yuhong Dai
Yong Zhang
Yue Zhang
Haoran Zheng
Ling Xiang
Liang Cheng
Xiaoqing Wang
Jie Zhang
Hairong Hao
De Huai

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1552752

Original Research

Accepted on 07 Jul 2025

Lipoprotein(a) as a predictor of mortality in hospitalised patients with ischaemic heart disease

in Cardiovascular Endocrinology

Wann Jia Loh
Xuan Han Koh
Colin Yeo
Ruan Xu Cong
Siang Chew CHAI
TarChoon Aw
Chew Kiat Heng
Roger Foo

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1541712

242 views

Review

Published on 07 Jul 2025

A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

in Cardiovascular Endocrinology

David Aristizábal-Colorado
David Corredor-Rengifo
Santiago Sierra-Castillo
Carolina López-Corredor
David-Alexander Vernaza-Trujillo
Danilo Weir-Restrepo
Juan S. Izquierdo-Condoy
Esteban Ortiz-Prado
Jorge Rico-Fontalvo
Juan-Esteban Gómez-Mesa

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1605746

868 views

Original Research

Published on 04 Jul 2025

Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting

in Cardiovascular Endocrinology

Feyisa Assefa Dhaba
Wubshet Abraham Alemu
Firaol Lamessa Kitila
Koricho Simie Tolla
Astarekew Alene
Zeru Seyoum Wendimagegn
Kedir Ali Getahun
Hassen Ahmed Yesuf
Surafel Mekasha Woldeyes

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1472300

619 views

Original Research

Published on 04 Jul 2025

Prospective analysis of metabolic syndrome and inflammation in aortic aneurysm risk: UK Biobank study

in Cardiovascular Endocrinology

Xinyi Liu
Hao Liu
Suwei Chen
Chen Gong
Yipeng Ge
Zhiyu Qiao
Chengnan Li
Junming Zhu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1612975

329 views

Original Research

Accepted on 02 Jul 2025

The Effect of Surgical Cure of Primary Hyperparathyroidism on Cardiac Electrical Activity. A Cross-Sectional Study

in Cardiovascular Endocrinology

Piotr Kmieć
Izabela Maria Karwacka-Bujak
Michał Bohdan
Renata Świątkowska-Stodulska
Krzysztof Sworczak

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1601897

141 views

Clinical Trial

Accepted on 02 Jul 2025

Interplay Between Triglyceride-Glucose Index and Cardiovascular Events in Hypertensive Patients with Controlled Blood Pressure (SBP<140 mmHg): Insights from the SPRINT Trial

in Cardiovascular Endocrinology

Chuanwei Li
Xiaoling Chen
Lili Wang
Yingying Jiang
Wenyi Tang
Jun Xiao
Wuquan Deng
Xiangpeng Ren

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1508667

142 views

Original Research

Published on 02 Jul 2025

Predicting major cardiac and cerebrovascular events in acute coronary syndrome patients using the thyroid hormone sensitivity index

in Cardiovascular Endocrinology

Hui He
Jun Wang
Long Xia
Tao Ye
Yan Luo
Qiang Chen
Qiao Feng
Xiufen Peng
Maoling Jiang
Hanxiong Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1543378

316 views

Original Research

Accepted on 30 Jun 2025

Association Between Residual Cholesterol and Vulnerable Non-Culprit Lesions Progressing to Major Adverse Cardiovascular Events

in Cardiovascular Endocrinology

Fengfeng Wang
Qun Li

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1603907

111 views

Original Research

Accepted on 30 Jun 2025

The expression profiles and roles of microRNAs in cardiac glucose metabolism

in Cardiovascular Endocrinology

Hua Qian
Ya-Fang Zhu
Nan-Nan Shen

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1565385